Liu Hui
Vermogen: - $ op 30-06-2026
Vermogen: - $ op 30-06-2026
Liu Hui currently works at Rallybio Corp., as Independent Director from 2022.
Dr. Hui also formerly worked at Novartis AG, as VP & Head-Business Development & Licensing from 2013 to 2015 and Merus NV, as Chief Business Officer & Executive Vice President from 2015 to 2024.
Dr. Hui received his undergraduate degree from Peking University and Masters Business Admin degree and doctorate degree from the University of Michigan.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
RALLYBIO CORPORATION -.--% | 19-12-2025 | 0 ( -.--% ) | - $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| RALLYBIO CORPORATION | Directeur/Bestuurslid | 04-04-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
| MERUS N.V. | Corporate Officer/Principal | 01-07-2024 |
| NOVARTIS AG | Corporate Officer/Principal | 01-01-2015 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merus NV
Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau